Reported 740,000 shares, unchanged from the prior quarter.
Reported value 11.1%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 4129000 |
| 2021-12-31 | 2849000 |
| 2022-03-31 | 977000 |
| 2022-06-30 | 681000 |
| 2022-09-30 | 475000 |
| 2022-12-31 | 527546 |
| 2023-03-31 | 3116000 |
| 2023-06-30 | 854805 |
| 2023-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2023 | Reduced | 0 | -899,700 (-100.0%) | 0 | $0 | 2023-11-14 | |
| Q2 2023 | Reduced | 899,700 | -2,216,300 (-71.1%) | < 0.01% | $854,805 | 2023-08-14 | |
| Q1 2023 | Added | 3,116,000 | +2,376,000 (321.1%) | < 0.01% | $3,116,000 | 2023-05-15 | |
| Q4 2022 | Unchanged | 740,000 | 0 (0.0%) | < 0.01% | $527,546 | 2023-02-14 | |
| Q3 2022 | Unchanged | 740,000 | 0 (0.0%) | < 0.01% | $475,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 740,000 | 0 (0.0%) | < 0.01% | $681,000 | 2022-08-15 | |
| Q1 2022 | Unchanged | 740,000 | 0 (0.0%) | < 0.01% | $977,000 | 2022-05-16 | |
| Q4 2021 | Unchanged | 740,000 | 0 (0.0%) | 0.01% | $2,849,000 | 2022-02-14 | |
| Q3 2021 | Unchanged | 740,000 | 0 (0.0%) | 0.02% | $4,129,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
58 managers reported AVROBIO INC COM (DE) for Q4 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors LLC | Unchanged | 4,520,863 | 0 | 0.39% | $3,222,923 | 5 qtrs |
| GMT CAPITAL CORP | Reduced | 3,309,859 | -184,631 | 0.11% | $2,359,598 | 8 qtrs |
| BlackRock Inc | Reduced | 1,520,340 | -483,231 | < 0.01% | $1,083,850 | 19 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Added | 1,469,892 | +288,135 | < 0.01% | $1,046,000 | 6 qtrs |
| VANGUARD GROUP INC | Added | 1,158,257 | +943 | < 0.01% | $825,721 | 19 qtrs |
| Aisling Capital Management LP | Unchanged | 1,009,779 | 0 | 0.47% | $716,943 | 17 qtrs |
| NATIXIS | New | 880,000 | +880,000 | < 0.01% | $627,352 | 1 qtr |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 862,267 | -359,874 | < 0.01% | $615,000 | 11 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC This report | Unchanged | 740,000 | 0 | < 0.01% | $527,546 | 19 qtrs |
| MILLENNIUM MANAGEMENT LLC | Reduced | 688,685 | -20,852 | < 0.01% | $491,000 | 15 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2022
- Filed
- February 14, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 740,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.